The pharmacological management of cardiovascular disease in people living with HIV (PLWH).

payth.elady61 shared this article with you from Inoreader The pharmacological management of cardiovascular disease in people living with HIV (PLWH). Via pubmed: "expert opin pharmac... Related Articles The pharmacological management of cardiovascular disease in people living with HIV (PLWH). Expert Opin Pharmacother. 2020 Dec 05;: Authors: Corbacho N, Mur I, Molas ME, Vidal F, Domingo P Abstract Introduction: Cardiovascular disease (CVD) continues to be an essential cause of morbidity and mortality among people living with human immunodeficiency virus infection (PLWH). Since the bulk of cardiovascular risk (CVR) factors are shared between PLWH and the general population, prevention and treatment strategies are similar. However, there are CVR factors particular to PLWH, which need separate consideration. These factors are those HIV-dependent, those related to HIV-derived consequences, and combination antiretroviral therapy (cART)-dependent. Areas covered: In this review, the authors discuss the management of CVD in PLWH, with a special interest in pharmacological treatment and drug-drug interactions with cART. Expert opinion: In recent years, we have witnessed a decreased CVD morbidity and mortality in PLWH, which probably reflects an improvement in the management of CVR factors and CVD in these patients, partially thanks to new developments in antiretroviral therapy. Therefore, although there is still room for improvement, at present, the old desideratum of equalling PLWH and the general population in terms of CVD incidence and prognosis is a little closer. PMID: 33283570 [PubMed - as supplied by publisher] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.